For example, machine learning algorithms and databases have identified ANGPTL4 as a potential prognostic biomarker for ccRCC patients (Wang et al., 2018; Zhang et al., 2020; Han and Song, 2022; Li L. et al., 2023). Here, ANGPTL4 is linked to nonpapillary renal cell carcinoma.